News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
BMS boosts cancer trials with Sarah Cannon’s clinical research platform
Bristol Myers Squibb (BMS) announced an expansion of its partnership with Sarah Cannon Research Institute (SCRI) to integrate BMS’s oncology pipeline into SCRI’s Accelero clinical
Behind the Science: Problem Solving Inside a Fast-Paced CDMO
When Gilbert Martinez, PhD talks about his work at AGC Biologics, he describes a world where the science moves fast, challenges appear without warning, and
Seattle’s AI-Biotech Leaders See Hype, Hope, and Hard Problems
A Seattle AI Leadership Summit co-hosted by Life Science Washington and Madrona brought together regional tech and biotech leaders to discuss the opportunities and challenges
Scientists create a supercomputer simulation that can reveal how the brain works, neuron by neuron
Researchers at Seattle’s Allen Institute and partner institutions in Japan created a whole-cortex mouse brain simulation using the Fugaku supercomputer. The simulation models nearly 10
Washington Research Foundation awards $5.2M to establish new clinical trials program
Washington Research Foundation has awarded a $5.2 million, three-year BioInnovation Grant to launch a new clinical trials program between Fred Hutch Cancer Center and Seattle
Allen Institute taps AWS, Google to spur ‘aha moments’ in neuroscience with new brain research platform
The Allen Institute launched the Brain Knowledge Platform, an AI-powered research tool that integrates neuroscience data from multiple species, institutions, and disease areas. The platform,
Nobel winner’s lab notches another breakthrough: AI-designed antibodies that hit their targets
UW’s Institute for Protein Design successfully used AI to create antibodies from scratch that bind precisely to their intended targets. These computer-designed molecules engaged real-world
Seattle startup Accipiter Bio emerges with $12.7M and big pharma deals for AI-designed proteins
Seattle-based Accipiter Biosciences has launched with $12.7 million in funding and partnerships with Pfizer and Kite Pharma to create AI-designed proteins capable of targeting multiple
OpenAI lands new pharma deals with Thermo Fisher and Lundbeck
OpenAI has entered a new collaboration with Lundbeck to expand the use of large language models in pharmaceutical research and drug development. Lundbeck, a global
AGC Biologics, Rarity PBC partner on gene therapy for ‘bubble baby’ disease
AGC Biologics has partnered with Rarity PBC to develop and manufacture RDP-101, a gene therapy designed to treat adenosine deaminase severe combined immunodeficiency disorder (ADA-SCID),
AI in Protein Design: Hype vs. Reality Explained by David Baker
In an interview with GEN, Nobel Laureate David Baker, PhD, director of the Institute for Protein Design at the University of Washington, reflected on the
‘Doctor in your pocket’: Xealth CEO Mike McSherry on selling to Samsung and the future of digital healthcare
Samsung has acquired Seattle-based digital health startup Xealth for approximately $115 million, marking a significant expansion of the tech giant’s push into digital healthcare. Founded